HEIDELBERG UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1386-01-01
- Employees
- -
- Market Cap
- -
Interaction Between Fluvoxamine and Sildenafil
Phase 1
Completed
- Conditions
- Healthy
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2005-09-15
- Lead Sponsor
- Heidelberg University
- Target Recruit Count
- 12
- Registration Number
- NCT00175981
- Locations
- 🇩🇪
Dept. of Internal Medicine VI, University of Heidelberg, Heidelberg, Baden-Württemberg, Germany
Clinical Comparison of RPDs Retained by Conical and Galvanoformed Double Crowns.
Phase 4
- Conditions
- Denture, Partial, RemovableDental Prosthesis RetentionOral HealthTooth Abrasion
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2005-09-15
- Lead Sponsor
- Heidelberg University
- Registration Number
- NCT00176215
- Locations
- 🇩🇪
University of Heidelberg, Heidelberg, Baden_Württemberg, Germany
Hypoxia Impairs Endothelial Function in HAPEs
Phase 1
Completed
- Conditions
- Healthy
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2005-09-15
- Lead Sponsor
- Heidelberg University
- Registration Number
- NCT00176007
Preoperative Twice Daily Chemoradiation in Addition to Chemotherapy Prior to Surgery in Stage III Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Completed
- Conditions
- Non-Small Cell Lung Cancer
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2008-04-22
- Lead Sponsor
- Heidelberg University
- Target Recruit Count
- 500
- Registration Number
- NCT00176137
Drug Transport in Patients With Anorexia Nervosa
- Conditions
- Anorexia Nervosa
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2005-09-15
- Lead Sponsor
- Heidelberg University
- Registration Number
- NCT00176150
- Locations
- 🇩🇪
Department of Internal Medicine VI, Clinical Pharmacology and Pharmacoepidemiology, Heidelberg, Germany
Complementary Therapies for the Reduction of Side Effects During Chemotherapy for Breast Cancer
Phase 4
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2007-04-19
- Lead Sponsor
- Heidelberg University
- Target Recruit Count
- 150
- Registration Number
- NCT00160901
- Locations
- 🇩🇪
Department of Complementary and Integrative Medicine, Heidelberg, Baden-Württemberg, Germany
NK-1 Antagonism of SLV317 in Humans
Phase 1
Completed
- Conditions
- Healthy
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2005-09-12
- Lead Sponsor
- Heidelberg University
- Target Recruit Count
- 18
- Registration Number
- NCT00160862
- Locations
- 🇩🇪
Dept. of Internal Medicine VI, University of Heidelberg, Heidelberg, Baden-Württemberg, Germany
Vasoreactivity in Carriers of Genetic Polymorphisms
Phase 1
- Conditions
- Healthy
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2005-09-12
- Lead Sponsor
- Heidelberg University
- Target Recruit Count
- 100
- Registration Number
- NCT00160888
- Locations
- 🇩🇪
Dept. of Internal Medicine VI, Heidelberg, Baden-Württemberg, Germany
Treating Climacteric Symptoms With a Complex Homeopathic Remedy
Phase 4
Completed
- Conditions
- MenopauseAnxiety DisordersDepression
- Interventions
- Drug: ovaria comp 10 globuli 3 times per day 24 weeks
- First Posted Date
- 2005-09-09
- Last Posted Date
- 2018-06-14
- Lead Sponsor
- Heidelberg University
- Target Recruit Count
- 102
- Registration Number
- NCT00152776
- Locations
- 🇩🇪
Department of Complementary and Integrative Medicine, Heidelberg, Baden-Württemberg, Germany
Rapamycin Use in Calcineurin Inhibitor (CNI)-Free Immunosuppression for Stabilization/Improvement of Renal Function After Heart Transplantation
Phase 4
Completed
- Conditions
- Heart TransplantationRenal Failure
- First Posted Date
- 2005-07-22
- Last Posted Date
- 2005-08-02
- Lead Sponsor
- Heidelberg University
- Target Recruit Count
- 40
- Registration Number
- NCT00123331
- Locations
- 🇩🇪
Medizinische Universitätsklinik, Kardiologie, Heidelberg, Germany
© Copyright 2025. All Rights Reserved by MedPath